SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer

Carla Maria Lourenco Alves, Daniel Elias, Maria Bibi Lyng, Martin Bak, Henrik Ditzel

Research output: Contribution to journalJournal articleResearchpeer-review

168 Downloads (Pure)

Fingerprint Dive into the research topics of 'SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences